Clinical trial
Safety, Immunogenicity, and Efficacy Studies of WRSS1, a Live Attenuated Shigella Sonnei Vaccine Candidate, in Healthy Thai Adults
NCT01080716 is registered in ClinicalTrials.gov with U.S. Army Medical Research and Development Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Immunogenicity, and Efficacy Studies of WRSS1, a Live Attenuated Shigella Sonnei Vaccine Candidate, in Healthy Thai Adults
- Lead sponsor
- U.S. Army Medical Research and Development Command
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- December 31, 2011
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.